Objective: Constitutively activating mutations of the thyrotrophin receptor (TSHR) are the main molecular cause of hyperfunctioning thyroid nodules (HTNs). The G protein coupling is an important and critical step in the TSHR signalling which mainly includes Gas, Gai and Gaq/11 proteins. Design: We investigated the in vitro consequences of overexpressing Ga proteins on signalling of the wild-type (WT) or mutated TSHR. Moreover, we investigated whether changes in Ga protein expression are pathophysiologically relevant in HTNs or cold thyroid nodules (CTNs).
Introduction
The thyrotrophin (TSH) receptor is known to couple to 11 different G protein a subunits in vitro. TSH receptor signalling mainly involves the G protein a subunits Gs, Gi and Gq/11 leading to an activation of the cAMP and the phospholipase C (PLC) pathways (1, 2) . While low concentrations of TSH lead to a sufficient stimulation of cAMP production, up to 100-fold concentrations of TSH are necessary to induce PLC activation (3) . The cAMP cascade is the major signal transduction pathway of the TSH receptor (TSHR) in vivo and has been shown to activate mitogenesis and thyroid hormone production (4) . Changes in G protein coupling and signal transduction have recently been demonstrated for the TSHR variant Y601H compared with the wildtype (WT) TSH receptor (5, 6) . As constitutively activating TSH receptor mutations which frequently occur in hyperfunctioning thyroid nodules (HTNs) cause changes within the intracellular receptor conformation, these mutations could also lead to variations of G protein coupling and signal transduction (5) . This hypothesis is also supported by the variable Gas or Gai protein expression in HTNs (7 -10) . However, it is not known whether the overexpression of the various Ga proteins has any effect on the signal transduction of the WT or mutated TSHR.
Constitutively activating TSH receptor mutations and, with a lower prevalence, mutations of the Gas protein have been shown to be the main molecular causes of HTNs (11 -16) . However, the relative contribution of constitutive TSHR activation and possible variations of G protein expression to the clinical phenotype of HTNs has been debated. Induction of Gas expression increases constitutive as well as stimulated cAMP accumulation. Investigations of G protein expression in HTNs have reported variable results by demonstrating increased, decreased or unchanged Gas protein levels (7 -10) . However, the molecular aetiology of these HTNs has, for the most part, not been determined. It is therefore not known whether the variable G protein expression reported for HTNs depends on their molecular aetiology.
The aim of our study was, therefore, to investigate the functional consequences for G protein a subunit overexpression on the signal transduction of the WT and mutated TSH receptors in coexpression experiments in COS 7 cells. Moreover, we also determined the expression of Ga subunits in HTNs with different molecular aetiologies and in cold thyroid nodules (CTNs) which also show increased proliferation (8) together with decreased thyroid hormone production.
Materials and methods

Samples
Specimens of 28 HTNs, 14 CTNs and adjacent thyroid tissue of consecutive patients undergoing thyroid resection for treatment of their nodular thyroid growth were obtained at surgery. Prerequisites for inclusion in the study were: the identification of a solitary HTN or a CTN as identified by ultrasound, increased or decreased circumscribed technetium uptake by the nodule with suppression of surrounding thyroid tissue on scintiscan (in the case of HTNs), and macroscopic and microscopic identification of the nodule by a pathologist. All patients with HTNs suffered from overt hyperthyroidism with suppressed TSH and elevated thyroid hormones and negative thyroid antibodies. All patients were euthyroid at the time of surgery. Tissue samples were shock-frozen in liquid nitrogen. Extraction of genomic DNA was performed from the HTNs and the surrounding normal tissue with a Qiagen tissue kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. Somatic TSH receptor mutations in HTNs were previously determined by denaturating gradient gel electrophoresis (DGGE) and subsequent direct sequencing of the positive bands (12) .
Membrane preparations were performed in membrane preparation buffer (40 mmol/l Tris/HCl, 250 mmol/l sucrose, 0.1 mmol/l dithiothreitol, 0.1 mmol/l phenylmethylsulphonylfluoride (pH 7.4). Tissue samples were homogenised in ice-cold membrane preparation buffer and centrifuged (700 g/ 10 min/4 8C). The supernatant was further centrifuged for 45 min at 60 000 g at 4 8C. The pellet was resuspended in membrane preparation buffer (membrane fraction) and the supernatant was used as the cytosolic fraction. Protein content was determined by the method of Bradford (17) . The study was approved by the local ethics committee. Informed consent was obtained from all patients before surgery.
Plasmid construction
G protein constructs were kindly provided by R K Sunhara (Southwestern Medical Center, University of Texas, Dallas, USA; Gas), R R Reed (Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Gai3), and M Strathmann and M I Simon (California Institute of Technology, Pasadena, USA; Gaq and Ga11). The coding sequence of Gas was cut by NcoI and HindIII, purified and subsequently subcloned into the EcoRV and HindIII sites of the pcDNA 3.1-Zeo vector (Invitrogen, Groningen, The Netherlands). Gai3 was cut by EcoRI and HindIII and subcloned into corresponding sites of the pcDNA 3.1-Zeo vector. Gaq was cut by NotI and BamHI and also subcloned into pcDNA 3.1-Zeo vector. The coding sequence of Ga11 was cut by Bsu15I and XhoI and subcloned into pcDNA 3.1-Zeo by EcoRV and XhoI. All subcloned fragments were confirmed by sequencing.
Cotransfection of TSHR and G proteins and functional characterisation
Transient expression of the wild-type and mutant TSHR was performed in 12-well plates (1 £ 10 5 COS 7 cells) using 1 mg total DNA per well (0.5 mg TSH receptor, 0.5 mg G protein) and FuGene6-reagent (Boehringer, Ingelheim, Germany) according to the manufacturer's instructions. Twenty-four hours after transfection the cells were prepared for cAMP assays by washing once with PBS buffer and preincubation for 15 min with 1 mmol/l isobutylmethylxanthine (Sigma, Munich, Germany) in serum-free Dulbecco's modified Eagle's medium (DMEM). Thereafter, cells were stimulated with bovine TSH for 1 h at 37 8C in the same buffer. The reactions were stopped by aspiration of the medium and addition of 0.1 mol/l HCl. Supernatants were collected, dried and resuspended in 200 ml Tris/ EDTA buffer (0.05 mol/l Tris, 4 mmol/l EDTA, pH 7.5). cAMP was assayed using a 3 H-cAMP RIA kit (Amersham Co., Amersham, Bucks, UK) according to the manufacturer's instructions.
For determination of the TSHR cell surface expression, transfected cells were incubated with antihuman TSHR antibody (2C11, Serotec Ltd, Oxford, Oxon, UK; 10 mg/ml in PBS containing 0.1% BSA). After two washes with PBS (0.1% BSA) cells were incubated with the fluorescent conjugated F(ab 0 )2 rabbit anti mouse IgG secondary antibody (Star9B, Serotec Ltd; 1:100 dilution in PBS containing 0.1% BSA) for 1 h on ice in the dark. The fluorescence of 10 000 cells per tube was assayed by a FACScan Cytofluorometer (Becton Dickinson, Tranklin Lakes, USA).
Stimulation of inositol phosphate formation
Inositol phosphates were measured as described (18) . Forty hours after transfection 2 £ 10 5 COS 7 cells were incubated with 2 mCi/ml [myo-
3 H]inositol (18.6 Ci/mmol, Amersham Pharmacia Biotech, Amersham, Bucks, UK) for 8 h. Thereafter, cells were preincubated in serum-free DMEM containing 10 mmol/l LiCl for 20 min. Subsequently, cells were stimulated with bovine TSH for 1 h as described before (18) . Stimulation was terminated by aspiration of the medium and addition of 0.5 ml 3% perchloric acid. TSH-induced increases in intracellular inositol phosphate (IP) levels were determined by anion exchange chromatography. IP values are expressed as the percentage of radioactivity incorporated in inositol phosphates and phosphatidyl inositols.
Western blot analysis
Equal amounts of protein were added to electrophoresis sample buffer, heated at 95 8C for 5 min and electrophoresed (25 mg protein/per lane for COS 7 cells, 6 mg/lane for thyroid samples) on a 10% polyacrylamide gel containing 0.1% sodium dodecylsulphate using the discontinuous buffer system described by Davis (19) . After electrophoresis the proteins were blotted (Semi dry blotter; BioRad, Hercules, CA, USA) onto nitro-cellulose membranes (Schleicher & Shuell, Dassel, Germany) and after blocking in 5% non-fat dry milk (NFDM) in Tris-buffered saline/Tween (TBS/T; 20 mmol/l Tris/HCl, pH 7.6, 150 mmol/l NaCl, 0.1% Tween 20) (1 h, room temperature (RT)) the membranes were probed overnight with G protein a subunit specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in TBS/T (20 mmol/l Tris/HCl, pH 7.6, 150 mmol/l NaCl, 0.05 mmol/l Tween 20, 5% BSA, 0.2 mg antibody/ml buffer). After washing in PBS/T (3 times, 5 min, RT) the membranes were probed (1 h, RT) with the secondary horseradish peroxidase-conjugated anti-rabbit antibody (1:2000 dilution in PBS/T and 5% NFDM; New England Biolabs, Beverly, USA) and finally washed 4 times with PBS/T each for 5 min. Following an incubation (5 min, RT) with chemiluminescence reagent (SuperSignal; Pierce, Rockford, IL, USA) the proteins were detected using the Chemi Imager 4000 System (Alpha Innotech Corporation, San Leandro, USA). 
Data analysis
Results
Functional characterisation of TSH receptor and G protein interaction
To investigate the functional influence of different overexpressed G protein a subunits on TSH receptor signalling, the TSH receptor and the Gas protein subunits were coexpressed in COS 7 cells and accumulation of cAMP and IP was determined with and without TSH stimulation. A high expression of G proteins in transfected cells could be demonstrated by Western blotting of COS 7 cells transiently transfected with plasmids containing cDNAs of Gas, i, q and 11 ( Fig. 1) . Transfection efficiency of the TSH receptor was 30 to 40% in all experiments as determined by FACS analysis, and surface expression of the receptor was readily detectable at high levels for all transfected TSH receptor constructs. We could not find any difference in the endogenous expression of Ga proteins by transfection of COS 7 cells with the WT TSHR or constitutively activating TSHR mutants. There was no difference in cell surface expression of the constitutively activated TSH receptor mutants Del613-621, I486F and V656F when coexpressed with Gas, Gi or Gq/11 protein and stimulated with TSH compared with the coexpression of the TSH receptor mutants DEL613 -621, I486F and V656F together with the empty expression vector (data not shown).
The overexpression of Gas protein increased the basal and the TSH-stimulated cAMP accumulation in COS 7 cells transiently cotransfected with the WT TSHR or the constitutively activating TSH receptor mutants DEL613 -621, I486F and V656F (Fig. 2) . In contrast to Gas protein, the overexpression of Gai 3 protein significantly decreased the stimulated cAMP accumulation of the coexpressed WT and mutated TSH receptors (Fig. 2) . Overexpression of Gas or Gai proteins did not significantly affect the basal and TSH-stimulated IP level of the WT TSH receptor (Fig. 3) . Moreover, coexpression of Gaq protein or Ga11 protein with the WT TSH receptor or TSH receptor mutants led to a strong increase in basal and stimulated IP 3 (Fig. 3) .
Expression of G protein a subunits in HTNs and CTNs
Gas protein content was decreased to 78% of the corresponding surrounding tissue in HTNs with a somatic constitutively activating TSH mutation (14 cases) compared with their corresponding surrounding tissues, while no significant differences in the expression of Gas protein could be found between CTNs (14 cases) and their corresponding surrounding tissues (Figs. 4  and 5 ). More than 50% of the HTNs showed a decreased Gas protein expression. In contrast to HTNs with a somatic TSH receptor mutation there was no significant decrease of Gas protein expression in HTNs without a TSH receptor or Gas protein mutation (14 cases) (Fig. 4) . Gai protein expression was not significantly changed in either HTNs or CTNs compared with their surrounding tissues. This was also true for Gas protein expression in CTNs (Fig. 4) . Gaq/11 protein content was unchanged in CTNs and HTNs compared with their corresponding surrounding tissues (Fig. 4) . The data in our patient population followed a Gaussian distribution (normality test passed), and no separate populations could be discerned. Despite the range of standard deviations no further statistical tests were performed.
Discussion
Our results showing an increased cAMP accumulation by coexpression of constitutively activating mutations of the TSHR with Gas subunits are in agreement with data showing that an overexpression of Gas protein increases the constitutive as well as the stimulated cAMP accumulation and the transcriptional activation of cAMP-dependent reporter genes (20) . The decreased TSH-stimulated accumulation of cAMP by coexpression of Gai together with the TSHR is most likely due to the known inhibitory potential of the overexpressed Gai protein subunits on adenylylcyclase activity (21) . TSHR coupling to Gai subunits has been found in in vitro experiments and has previously been described as functionally relevant in vivo (1, 2) . Coexpression of Gai with mutated TSHR showed an inhibition of stimulated cAMP and IP (in the case of I486F) indicating the possibility for an inhibition of TSHR signalling by Gai overexpression. Overexpression of Gaq protein or Ga11 protein subunits also led to an increase in basal Figure 3 Inositol triphosphate accumulation in COS 7 cells cotransfected with different TSHR constructs and Ga protein subunits. The basal IP production of the WT TSHR was set at 1 and all other data are expressed as fold of the basal IP production of the WT TSHR. The cells were stimulated with 100 mU/ml bovine TSH for 1 hour as indicated. Data are given as means^S.E.M. of three independent measurements. *P , 0:05; **P , 0:01; ***P , 0:001:
and stimulated IP accumulation in COS 7 cells when coexpressed with the WT TSH receptor or the TSH receptor mutants. The IP accumulation was not related to the constitutive activity of the TSH receptor mutants. Therefore, increased Gaq/11 protein expression in vitro can lead to an increased TSHR-PLC signalling. Results from in vitro experiments often differ from in vivo situations. These differences can be caused by the use of artificial promoters, heterologous cell systems and transient transfections in the in vitro experiments. Therefore, the results of our in vitro experiments should be handled with caution when used to analyse the in vivo situation in HTNs.
To investigate the relevance of our in vitro coexpression data in vivo the expression of Ga proteins in HTNs and CTNs was determined by Western blotting. Reduced expression of Gas proteins in HTNs (9), increased Gas protein expression (7, 8) or no change in Gas protein expression (10) in HTNs have recently been reported. The samples examined in former studies of Gas protein expression, except those described by Derwahl et al. (7), were not analysed for mutations in the TSHR or in the Gas protein (8, 10, 22, 23) or have only been screened for Gas protein mutations (22) . Some investigators used, in addition to Western blotting, ADP ribosylation experiments to investigate G protein expression (7) (8) (9) . A further aspect reducing the strength of the former results is the low number of HTNs investigated, 2 (23), 7 (9), 4 (8), 10 (7) and 9 (10) respectively. An increased Gas and Gai protein content in 5 HTNs with and 5 HTNs without TSHR or Gsa protein mutation has recently been reported (7). Our results of decreased expression of Gas in HTNs with TSHR mutations are difficult to reconcile with this report by Derwahl and co-workers. We and others (8) have shown that both Ga protein and cAMP content in thyroid tumours varies greatly. However, the HTNs included in our study were screened for TSH receptor mutations and mutations in the Gas protein gene by DNA sequencing and DGGE (12, 16, 24) and were also examined for their clonality (25) . In 58% of the HTNs somatic TSHR or Gas protein mutations were identified, making a constitutive activation of the cAMP pathway in these HTNs very likely (12) . However, 42% of the HTNs were negative for TSHR or Gas protein mutations even with the sensitive DGGE method (12, 16, 24) , which indicates that in HTNs without TSHR mutation different growth stimulating mechanisms bypassing the TSHR are likely to exist. Therefore, the molecular cause and the activated signalling cascade in these HTNs are currently not known, which makes them unsuitable candidates for studies trying to elucidate the in vivo consequences of chronic cAMP activation on the pattern of Ga protein subunit expression. Therefore, our clinical and molecular characterisation allows us to relate the expression of Ga subunits to defined clinical entities such as HTNs with TSHR mutations compared with HTNs without TSHR or Gas mutations and with CTNs. 
